Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke
European Journal of Neurology2019Vol. 26(8), pp. 1105–1110
Citations Over TimeTop 10% of 2019 papers
Xiding Pan, Danni Zheng, Yu Zheng, Po‐Chi Chan, Yu-Ting Lin, Jianjun Zou, Junshan Zhou, Jianhong Yang
Abstract
Tirofiban in combination with EVT was associated with a lower mRS score at 3 months and NIHSS score at 24 h. It was not associated with a higher rate of sICH, in-hospital death and death at 3 months.
Related Papers
- → Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke(2022)185 cited
- → Safety of Tirofiban in Acute Ischemic Stroke(2011)170 cited
- → Association of baseline hematoma and edema volumes with one-year outcome and long-term survival after spontaneous intracerebral hemorrhage: A community-based inception cohort study(2020)13 cited
- → Adjunct Intraarterial or Intravenous Tirofiban Versus No Tirofiban After Successful Recanalization of Basilar Artery Occlusion Stroke: The BASILAR Registry(2024)2 cited
- → Morbilidad de la hemorragia intracerebral(1998)9 cited